PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 17, 20254 citationsOpen Access

E2 displacement of CIP2A from TOPBP1 activates the DNA damage response during papillomavirus life cycles

View Full Paper
APApurva T. PrabhakarCJClaire D. JamesANA. Nguyen

Key Points

  • E2 activates the DNA damage response during the papillomavirus life cycle, enhancing viral replication.
  • The study found that E2 displaces CIP2A from TOPBP1, leading to ATM phosphorylation and DDR activation.
  • CIP2A inhibition results in increased acetylation of viral and host proteins, boosting DDR and promoting cell proliferation.
  • ATM inhibition showed potential as a therapeutic strategy in treating HPV-related early preneoplasia and oropharyngeal cancers.

Abstract

The papillomavirus life cycle is intricately linked to epithelial differentiation, and the virus manipulates the differentiation process to facilitate viral production. One such manipulation is activation of the DNA damage response (DDR) which promotes viral replication via homologous recombination. This report demonstrates that the papillomavirus transcription/replication/segregation factor E2 activates the DNA damage response (DDR). During differentiation, E2 displacement of CIP2A from TOPBP1 causes CIP2A to bind and inhibit PP2A resulting in DDR activation via ATM phosphorylation. The DDR promotes inhibitory interaction of DBC1 with the class III deacetylase SIRT1, which further boosts the DDR via increased acetylation and stability of viral and host proteins. E2 forms a complex with TOPBP1 and ATM, while preventing ATR activation by blocking TOPBP1-ATR interaction. This ATM up ATR down phenotype promotes viral replication via ATM promotion of homologous recombination, and cell proliferation via inhibition of ATR. We demonstrate this mechanism of DDR activation in multiple systems: keratinocytes expressing only E2, in foreskin keratinocytes immortalized by HPV16, in HPV16 positive keratinocytes derived from a cervical lesion, in pre-neoplastic lesions induced by mouse papillomavirus MmuPV1, in head and neck cancer cell lines that retain E2 expression, and in HPV16 positive oropharyngeal patient derived xenografts that retain E2 expression. ATM inhibition preferentially killed cells expressing E2, presenting a novel strategy for treating HPV early preneoplasia and a large subset of HPV+ oropharyngeal cancers retaining E2 expression and episomal genomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Prabhakar et al. (2025) studied this question.

synapsesocial.com/papers/68f19f20de32064e504ddee5https://doi.org/10.1101/2025.10.15.682653
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Correlation Between Cyclin B1 Immunostaining in Cervical Biopsies and HPV Detection by PCR2009 · 6 citations
  2. 2Properties of a non‐tumorigenic human cervical keratinocyte cell line1989 · 270 citations
  3. 3TOPBP1 recruits TOP2A to ultra-fine anaphase bridges to aid in their resolution2015 · 91 citations
  4. 4MDC1 Interacts with TOPBP1 to Maintain Chromosomal Stability during Mitosis2019 · 154 citations
  5. 5Oligomerization of TopBP1 is necessary for the localization of TopBP1 to mitotic centrosomes2013 · 7 citations